logo
Are You Vitamin-Deficient? Nutritionist Reveals How Your Body Tries To Tell You Before It's Too Late

Are You Vitamin-Deficient? Nutritionist Reveals How Your Body Tries To Tell You Before It's Too Late

India.com21-05-2025

In today's fast-paced world, vitamin deficiencies are becoming increasingly common. Surprisingly, it's not always due to a lack of food but the kind of lifestyle we lead. From excessive stress and processed food intake to erratic eating schedules, limited sun exposure, and inadequate sleep, our daily habits are silently sabotaging our nutrient absorption. The human body, however, is incredibly intelligent. It doesn't just break down quietly—it sends out SOS signals long before things get worse.
According to Mugdha Pradhan, functional nutritionist and founder of iThrive, a Pune-based wellness platform, many chronic health issues she encounters stem from simple vitamin deficiencies. "I've worked with hundreds of individuals with deep-rooted issues, and more often than not, the real problem turned out to be a missing vitamin or two," she says. Understanding these early warning signs can be the key to preventing long-term complications.
1. Constant Fatigue Despite Rest
If you feel tired all the time—even after sleeping well—you might be running low on B-complex vitamins. Each B vitamin (like B1, B2, B3, B5, B6, and B12) plays a crucial role in energy production. They're essential for the electron transport chain, which is how your body makes ATP, the main fuel for your cells. Without them, energy levels plummet, leaving you exhausted no matter how much rest you get.
2. Frequent Illnesses and Low Immunity
Falling sick too often? Frequent colds, coughs, or infections could signal a weakened immune system caused by low Vitamin C and Vitamin D levels. Vitamin C strengthens your immune defense, while Vitamin D helps activate immune responses. With modern lifestyles reducing sunlight exposure and limiting fresh, nutrient-rich foods, deficiencies in these vital vitamins are on the rise.
3. Excessive Hair Fall or Thinning
Notice more hair in your comb than usual? Biotin (Vitamin B7) might be lacking. Biotin helps maintain hair strength and promotes growth. Deficiency in biotin or other B vitamins can weaken hair from the roots, leading to noticeable thinning and increased hair loss.
4. Cracked Lips and Mouth Sores
Painful cracks at the corners of your mouth or frequent mouth ulcers often point to low levels of Vitamins B2, B3, or B12. These vitamins are essential for tissue repair and healthy skin. Without them, your skin becomes more prone to dryness, cracking, and slow healing.
5. Unexplained Bone Pain and Muscle Cramps
If you're dealing with persistent bone aches or cramps—especially at night—it may be time to check your Vitamin D levels. This sunshine vitamin is crucial for calcium absorption and bone health. A deficiency can lead to brittle bones, joint pain, and muscular weakness that doesn't improve with rest or routine stretches.
What You Can Do
If any of these symptoms resonate with you, don't ignore them. Your body is trying to tell you something important. A simple blood test can help identify deficiencies. Once diagnosed, you can begin healing through a mix of natural foods, targeted supplements, and lifestyle changes. Nutrient-rich foods, outdoor walks, regular meals, and good sleep can all make a huge difference.
Ignoring these early signs can result in more serious health problems over time. So, listen to your body—it knows when something's off. Acting early can help you regain energy, immunity, and well-being naturally.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Army unveils oxygen plant for high-altitude emergencies in Arunachal's Tawang
Army unveils oxygen plant for high-altitude emergencies in Arunachal's Tawang

The Hindu

timean hour ago

  • The Hindu

Army unveils oxygen plant for high-altitude emergencies in Arunachal's Tawang

GUWAHATI The Indian Army has unveiled an oxygen generation plant for high-altitude emergencies in western Arunachal Pradesh's Tawang. The plant at the Military Hospital in Tawang was engineered for rapid deployment and optimal efficiency under extreme conditions. It is a self-contained unit capable of generating medical-grade oxygen round the clock. The facility, built with contributions from the Soldiers' Independent Rehabilitation Foundation, a Pune-based NGO, was commissioned by the General Officer Commanding of the Gajraj Corps' Ball of Fire Division on Thursday (June 5, 2025). The plant would 'serve as a critical life-saving facility for both the armed forces personnel and local civilian populations, especially in the strategically sensitive and geographically challenging terrain of the region,' a Defence Ministry statement said. Most of the habitations in Tawang district are at an altitude of at least 10,000 ft. above mean sea level. Oxygen levels are low in these places. On June 3, the Army's Spear Corps carried out a major civic outreach initiative under Operation Sadbhavana in the Ziro Valley in Arunachal Pradesh's Lower Subansiri district. The activities included the distribution of stationery kits to primary school children, the installation of mobile toilet cubicles to improve public hygiene and sanitation, and the establishment of open-air gym equipment to promote fitness and community well-being.

Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment
Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment

Business Standard

time3 hours ago

  • Business Standard

Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment

Dr Reddy's Laboratories on Thursday said it has joined hands with global biotech firm Alvotech to co-develop and commercialise a biosimilar product for treating multiple types of cancer. The Hyderabad-based drug major has entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets, Dr Reddy's Laboratories said in a statement. Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were USD 29.5 billion. The collaboration combines Dr Reddy's and Alvotech's proven capabilities in biosimilars thereby speeding up the development process and extending the global reach for this biosimilar candidate, the company noted. "It further enables us to increase the availability of cost-effective, critical biologic medications to patients world-wide," he added. Dr Reddy's shares were trading 3.49 per cent up at Rs 1,295.80 apiece on BSE.

Dr Reddy's–Alvotech deal: Why investors are bullish
Dr Reddy's–Alvotech deal: Why investors are bullish

New Indian Express

time4 hours ago

  • New Indian Express

Dr Reddy's–Alvotech deal: Why investors are bullish

CHENNAI: Shares of Dr Reddy's Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a global licensing agreement with Alvotech, an Iceland-based biopharmaceutical company. Under this agreement, the two firms will codevelop, manufacture, and commercialise a biosimilar candidate to Keytruda (called as pembrolizumab by the biological name) — a blockbuster cancer immunotherapy drug originally developed by the US pharma major Merck & Co., also known as MSD Pharmaceuticals outside US. Keytruda, prescribed for the treatment of various cancers including melanoma, non-small cell lung cancer, and head and neck cancers, in adults and children, is one of the most sold drugs of Merck from its original research. According to Merck's 2024 sales data, this drug alone contributed over $29.5 billion in revenue for the company, which also makes it one of the world's top-selling drugs. This drug is in demand as it is used in advanced, metastatic, or recurrent cancers that are not responding to other treatments or cannot be removed by surgery. Keytruda can also be used to prevent cancer recurrence after surgery. A biosimilar is a generic equivalent of a biological drug. In this case, the biosimilar -- pembrolizumab-- can enter the market once Merck's patent is expired. There are several drug firms work on this bio-molecule currently worldwide, and Alvotech is one of the frontrunners. The licensing deal signed between Dr Reddy's and Alvotech marks a strategic expansion of the former's biosimilars pipeline, aligning with the company's ambition to build a strong presence in the global oncology space.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store